Acrivon therapeutics announces the appointment of seasoned biopharma executive charles baum, m.d., ph.d., a recognized leader in clinical precision oncology, to its board of directors

Dr. baum comes with more than 30 years of biopharma industry leadership experience, including at mirati therapeutics, pfizer and schering-plough dr. baum comes with more than 30 years of biopharma industry leadership experience, including at mirati therapeutics, pfizer and schering-plough
ACRV Ratings Summary
ACRV Quant Ranking